Operating Income (Loss) in USD of IDEXX LABORATORIES INC /DE from Q1 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
IDEXX LABORATORIES INC /DE quarterly and annual Operating Income (Loss) history and change rate from Q1 2010 to Q3 2025.
  • IDEXX LABORATORIES INC /DE Operating Income (Loss) for the quarter ending 30 Sep 2025 was $354,846,000, a 17% increase year-over-year.
  • IDEXX LABORATORIES INC /DE Operating Income (Loss) for the twelve months ending 30 Sep 2025 was $1,306,112,000, a 17% increase year-over-year.
  • IDEXX LABORATORIES INC /DE annual Operating Income (Loss) for 2024 was $1,128,337,000, a 2.8% increase from 2023.
  • IDEXX LABORATORIES INC /DE annual Operating Income (Loss) for 2023 was $1,097,128,000, a 22% increase from 2022.
  • IDEXX LABORATORIES INC /DE annual Operating Income (Loss) for 2022 was $898,765,000, a 3.6% decline from 2021.
Source SEC data
View on sec.gov
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

IDEXX LABORATORIES INC /DE Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,306,112,000 $354,846,000 +$50,954,000 +17% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $1,255,158,000 $373,046,000 +$109,245,000 +41% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $1,145,913,000 $316,534,000 +$17,576,000 +5.9% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $1,128,337,000 $261,686,000 +$16,384,000 +6.7% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $1,111,953,000 $303,892,000 +$28,609,000 +10% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $1,083,344,000 $263,801,000 -$32,343,000 -11% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025 2025 Q2
Q1 2024 $1,115,687,000 $298,958,000 +$18,559,000 +6.6% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $1,097,128,000 $245,302,000 +$18,775,000 +8.3% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $1,078,353,000 $275,283,000 +$30,455,000 +12% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024 2024 Q3
Q2 2023 $1,047,898,000 $296,144,000 +$117,078,000 +65% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $930,820,000 $280,399,000 +$32,055,000 +13% 01 Jan 2023 31 Mar 2023 10-Q 01 May 2024 2024 Q1
Q4 2022 $898,765,000 $226,527,000 +$27,336,000 +14% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
Q3 2022 $871,429,000 $244,828,000 +$18,866,000 +8.3% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023 2023 Q3
Q2 2022 $852,563,000 $179,066,000 -$80,187,000 -31% 01 Apr 2022 30 Jun 2022 10-Q 01 Aug 2023 2023 Q2
Q1 2022 $932,750,000 $248,344,000 +$722,000 +0.29% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q4 2021 $932,028,000 $199,191,000 +$14,096,000 +7.6% 01 Oct 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
Q3 2021 $917,932,000 $225,962,000 +$54,106,000 +31% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022 2022 Q3
Q2 2021 $863,826,000 $259,253,000 +$66,005,000 +34% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022 2022 Q2
Q1 2021 $797,821,000 $247,622,000 +$103,297,000 +72% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q4 2020 $694,524,000 $185,095,000 +$69,464,000 +60% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
Q3 2020 $625,060,000 $171,856,000 +$32,054,000 +23% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $593,006,000 $193,248,000 +$28,973,000 +18% 01 Apr 2020 30 Jun 2020 10-Q 30 Jul 2021 2021 Q2
Q1 2020 $564,033,000 $144,325,000 +$11,187,000 +8.4% 01 Jan 2020 31 Mar 2020 10-Q 04 May 2021 2021 Q1
Q4 2019 $552,846,000 $115,631,000 +$284,000 +0.25% 01 Oct 2019 31 Dec 2019 10-K 14 Feb 2020 2019 FY
Q3 2019 $552,562,000 $139,802,000 +$22,452,000 +19% 01 Jul 2019 30 Sep 2019 10-Q 29 Oct 2020 2020 Q3
Q2 2019 $530,110,000 $164,275,000 +$18,681,000 +13% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $511,429,000 $133,138,000 +$20,094,000 +18% 01 Jan 2019 31 Mar 2019 10-Q 30 Apr 2020 2020 Q1
Q4 2018 $491,335,000 $115,347,000 +$17,539,000 +18% 01 Oct 2018 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $473,796,000 $117,350,000 +$16,937,000 +17% 01 Jul 2018 30 Sep 2018 10-K 14 Feb 2020 2019 FY
Q2 2018 $456,859,000 $145,594,000 +$23,030,000 +19% 01 Apr 2018 30 Jun 2018 10-K 14 Feb 2020 2019 FY
Q1 2018 $433,829,000 $113,044,000 +$20,801,000 +23% 01 Jan 2018 31 Mar 2018 10-K 14 Feb 2020 2019 FY
Q4 2017 $413,028,000 $97,808,000 +$13,983,000 +17% 01 Oct 2017 31 Dec 2017 10-K 15 Feb 2019 2018 FY
Q3 2017 $399,045,000 $100,413,000 +$11,954,000 +14% 01 Jul 2017 30 Sep 2017 10-K 15 Feb 2019 2018 FY
Q2 2017 $387,091,000 $122,564,000 +$18,402,000 +18% 01 Apr 2017 30 Jun 2017 10-K 15 Feb 2019 2018 FY
Q1 2017 $368,689,000 $92,243,000 +$18,450,000 +25% 01 Jan 2017 31 Mar 2017 10-K 15 Feb 2019 2018 FY
Q4 2016 $350,239,000 $83,825,000 +$16,914,000 +25% 01 Oct 2016 31 Dec 2016 10-K 16 Feb 2018 2017 FY
Q3 2016 $333,325,000 $88,459,000 +$16,564,000 +23% 01 Jul 2016 30 Sep 2016 10-K 16 Feb 2018 2017 FY
Q2 2016 $316,761,000 $104,162,000 +$15,859,000 +18% 01 Apr 2016 30 Jun 2016 10-K 16 Feb 2018 2017 FY
Q1 2016 $300,902,000 $73,793,000 +$990,000 +1.4% 01 Jan 2016 31 Mar 2016 10-K 16 Feb 2018 2017 FY
Q4 2015 $299,912,000 $66,911,000 +$32,110,000 +92% 01 Oct 2015 31 Dec 2015 10-K 17 Feb 2017 2016 FY
Q3 2015 $267,802,000 $71,895,000 -$294,000 -0.41% 01 Jul 2015 30 Sep 2015 10-K 17 Feb 2017 2016 FY
Q2 2015 $268,096,000 $88,303,000 +$5,084,000 +6.1% 01 Apr 2015 30 Jun 2015 10-K 17 Feb 2017 2016 FY
Q1 2015 $263,012,000 $72,803,000 +$2,757,000 +3.9% 01 Jan 2015 31 Mar 2015 10-K 17 Feb 2017 2016 FY
Q4 2014 $260,255,000 $34,801,000 -$26,527,000 -43% 01 Oct 2014 31 Dec 2014 10-K 17 Feb 2016 2015 FY
Q3 2014 $286,782,000 $72,189,000 +$6,704,000 +10% 01 Jul 2014 30 Sep 2014 10-K 17 Feb 2016 2015 FY
Q2 2014 $280,078,000 $83,219,000 +$4,456,000 +5.7% 01 Apr 2014 30 Jun 2014 10-K 17 Feb 2016 2015 FY
Q1 2014 $275,622,000 $70,046,000 +$8,858,000 +14% 01 Jan 2014 31 Mar 2014 10-K 17 Feb 2016 2015 FY
Q4 2013 $266,764,000 $61,328,000 -$2,099,000 -3.3% 01 Oct 2013 31 Dec 2013 10-K 17 Feb 2015 2014 FY
Q3 2013 $268,863,000 $65,485,000 +$2,573,000 +4.1% 01 Jul 2013 30 Sep 2013 10-K 17 Feb 2015 2014 FY
Q2 2013 $266,290,000 $78,763,000 +$2,946,000 +3.9% 01 Apr 2013 30 Jun 2013 10-K 17 Feb 2015 2014 FY
Q1 2013 $263,344,000 $61,188,000 +$781,000 +1.3% 01 Jan 2013 31 Mar 2013 10-K 17 Feb 2015 2014 FY
Q4 2012 $262,563,000 $63,427,000 +$8,128,000 +15% 01 Oct 2012 31 Dec 2012 10-K 18 Feb 2014 2013 FY
Q3 2012 $254,435,000 $62,912,000 +$6,816,000 +12% 01 Jul 2012 30 Sep 2012 10-K 18 Feb 2014 2013 FY
Q2 2012 $247,619,000 $75,817,000 +$4,519,000 +6.3% 01 Apr 2012 30 Jun 2012 10-K 18 Feb 2014 2013 FY
Q1 2012 $243,100,000 $60,407,000 +$6,875,000 +13% 01 Jan 2012 31 Mar 2012 10-K 18 Feb 2014 2013 FY
Q4 2011 $236,225,000 $55,299,000 +$4,495,000 +8.8% 01 Oct 2011 31 Dec 2011 10-K 19 Feb 2013 2012 FY
Q3 2011 $231,730,000 $56,096,000 +$6,282,000 +13% 01 Jul 2011 30 Sep 2011 10-K 19 Feb 2013 2012 FY
Q2 2011 $225,448,000 $71,298,000 +$16,463,000 +30% 01 Apr 2011 30 Jun 2011 10-K 19 Feb 2013 2012 FY
Q1 2011 $208,985,000 $53,532,000 +$5,104,000 +11% 01 Jan 2011 31 Mar 2011 10-K 19 Feb 2013 2012 FY
Q4 2010 $203,881,000 $50,804,000 01 Oct 2010 31 Dec 2010 10-K 17 Feb 2012 2011 FY
Q3 2010 $49,814,000 01 Jul 2010 30 Sep 2010 10-K 17 Feb 2012 2011 FY
Q2 2010 $54,835,000 01 Apr 2010 30 Jun 2010 10-K 17 Feb 2012 2011 FY
Q1 2010 $48,428,000 01 Jan 2010 31 Mar 2010 10-K 17 Feb 2012 2011 FY

IDEXX LABORATORIES INC /DE Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $1,128,337,000 +$31,209,000 +2.8% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 $1,097,128,000 +$198,363,000 +22% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 $898,765,000 -$33,263,000 -3.6% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 $932,028,000 +$237,504,000 +34% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 $694,524,000 +$141,678,000 +26% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023 2022 FY
2019 $552,846,000 +$61,511,000 +13% 01 Jan 2019 31 Dec 2019 10-K 16 Feb 2022 2021 FY
2018 $491,335,000 +$78,307,000 +19% 01 Jan 2018 31 Dec 2018 10-K 12 Feb 2021 2020 FY
2017 $413,028,000 +$62,789,000 +18% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $350,239,000 +$50,327,000 +17% 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
2015 $299,912,000 +$39,657,000 +15% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018 2017 FY
2014 $260,255,000 -$6,507,000 -2.4% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017 2016 FY
2013 $266,762,000 +$4,199,000 +1.6% 01 Jan 2013 31 Dec 2013 10-K 17 Feb 2016 2015 FY
2012 $262,563,000 +$26,338,000 +11% 01 Jan 2012 31 Dec 2012 10-K 17 Feb 2015 2014 FY
2011 $236,225,000 +$32,344,000 +16% 01 Jan 2011 31 Dec 2011 10-K 18 Feb 2014 2013 FY
2010 $203,881,000 01 Jan 2010 31 Dec 2010 10-K 19 Feb 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.